公司資料
Cardiol Therapeutics Inc 股價、新聞與催化劑
- 股票代碼:
- CRDL
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Canada and listed in the U
股票表現
1.56 USD (-6.02%)
收盤價
最後更新: 2026年10月1日
133M USD
市值
股價為何變動
截至 2026年10月1日，CRDL 下跌 6.02%，收於 $1.56。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Cardiol Therapeutics is a biotechnology company focused on inflammatory heart disease and cardiology-related immunology. Its story centers on whether anti-inflammatory approaches can improve cardiac outcomes in a focused setting.
所在地與產業分類
Cardiol Therapeutics is headquartered in Canada and listed in the U.S. market. It sits in specialty cardiology biotechnology.
商業模式特徵
The company depends on clinical data, translational confidence, and the ability to keep a narrow cardiovascular pipeline moving. Investors watch efficacy, safety, and proof-of-concept work.
生技產業定位
Cardiol occupies a specialized cardio-immunology niche within biotech. The stock is catalyst-sensitive because the market needs evidence that the platform can matter in cardiac disease.
未來催化劑
- CRDL is a small-cap biotech / diagnostics name with catalysts around product and pipeline updates, plus any strategic step that clarifies the company's direction. The market will care about whether there is still a viable growth path.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。